Interpace Biosciences, Inc. (IDXG)

Interpace Biosciences Revenue

Interpace Biosciences had revenue of $11.52M in the quarter ending March 31, 2025, with 13.14% growth. This brings the company's revenue in the last twelve months to $48.26M, up 19.50% year-over-year. In the year 2024, Interpace Biosciences had annual revenue of $46.93M with 17.21% growth.

• Revenue (ttm): 48.26M
• Revenue Growth: +19.50%
• P/S Ratio: 0.07
• Revenue / Employee: 434.80K
• Employees: 111
• Market Cap: 3.45M

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2024	46.93M	6.89M	17.21%
Dec 31, 2023	40.04M	8.20M	25.75%
Dec 31, 2022	31.84M	-1.28M	-3.86%
Dec 31, 2021	33.12M	719.00K	2.22%
Dec 31, 2020	32.40M	8.18M	33.77%